NewsBenzinga阿普瑞亚治疗宣布其WEE1抑制剂APR-1051在晚期实体肿瘤患者中进行的1期ACESOT-1051研究的最新中期结果摘要已被接受在分子靶点与癌症治疗研讨会上进行口头报告 阿普瑞亚治疗宣布其WEE1抑制剂APR-1051在晚期实体肿瘤患者中进行的1期ACESOT-1051研究的最新中期结果摘要已被接受在分子靶点与癌症治疗研讨会上进行口头报告 Benzinga 2026.09.22 12:33 (GMT+0) Open on Benzinga Other news Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.04 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15.1 Billion CoreWeave’s CEO Says the Market Doesn’t Understand His Company. Whether or Not It Does Isn’t What Matters Here. Chevron Stock Price Targets Are Up and Put Credit Spreads Are Attractive to Value Players Traders Give Google a 70% Chance of Having the Best AI Model. Most People Can’t Even Use It Yet. Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review Ahead of General Motors Earnings, Here's What Barchart Data Says Comes Next for GM Stock
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.04 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $15.1 Billion
CoreWeave’s CEO Says the Market Doesn’t Understand His Company. Whether or Not It Does Isn’t What Matters Here.
